Edward Bataillard
Imperial College Healthcare NHS Trust(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Cutaneous lymphoproliferative disorders research, T-cell and Retrovirus Studies
Most-Cited Works
- → Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review(2021)58 cited
- → No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer(2017)39 cited
- → Ruxolitinib for tocilizumab‐refractory severe COVID‐19 infection(2020)37 cited
- → Efficacy of Subsequent Novel Targeted Therapies, Including Repeated Venetoclax-Rituximab (VenR), in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Previously Treated with Fixed-Duration Venr in the Murano Study(2020)22 cited
- → Lesson of the month 2: Non-uraemic calciphylaxis – an unexpected differential diagnosis for a necrotic ulcer(2015)5 cited
- → TRAIL (Tolerability of R-CHOP in Aggressive non-Hodgkin Lymphoma): A Predictive Algorithm to Support Clinical Decision-Making(2020)2 cited
- → Multi-Centre Real-World Outcomes of Large B-Cell Lymphoma Patients Treated with 2L Axicabtagene Ciloleucel in the UK(2024)1 cited
- → 459 | OUTCOMES OF SECOND‐LINE AXICABTAGENE CILOLEUCEL FOR LARGE B‐CELL LYMPHOMA IN THE UK(2025)
- → Outcomes of second‐line axicabtagene ciloleucel for large B‐cell lymphoma in the UK(2026)
- → 15 | EARLY PET RESPONSE PREDICTS RISK OF RELAPSE AFTER 2L AXI‐CEL IN LARGE B‐CELL LYMPHOMA(2025)